Clinical Trials Logo

Postpartum Preeclampsia clinical trials

View clinical trials related to Postpartum Preeclampsia.

Filter by:

NCT ID: NCT06310720 Recruiting - Clinical trials for Postpartum Depression

Postpartum Video Education in High Risk Populations

Start date: May 9, 2024
Phase: N/A
Study type: Interventional

This is a prospective, single-center, randomized control study to determine if video education at the time of postpartum discharge improves patient knowledge on the warning signs for the top three causes of severe maternal morbidity (infection, hemorrhage, and blood pressure disorders) in the first seven days following delivery for self-identified, Black, Latinx, other with two or more self-identified races, Medicaid, and/or uninsured postpartum individuals. Participants will be randomized to written discharge education + video education (intervention) vs standard discharge education (control). They will complete a baseline questionnaire and a post-discharge education questionnaire during their postpartum stay to assess for knowledge improvement. The investigators hypothesize that video education will improve patient's knowledge of severe maternal morbidity warning signs.

NCT ID: NCT05849103 Recruiting - Clinical trials for Hypertension, Pregnancy-Induced

Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy

Start date: May 8, 2023
Phase: N/A
Study type: Interventional

Investigators propose a comprehensive management program for postpartum patients with HDP who are at risk for severe maternal morbidity and mortality. Our program will emphasize three key components: 1) self-monitoring of blood pressures with app-based reporting connected to our electronic health record, 2) blood pressure management directed by a program navigator with guideline and physician support and 3) facilitated transitions of care to primary care clinicians for hypertension management. Investigators will randomize 300 patents with HDP on postpartum day one with follow up through 3 months postpartum. Primary outcome will be blood pressure reporting at 7-10 postpartum. Secondary outcomes include blood pressure control at 7-10 days postpartum, identification and treatment of severe blood pressures, severe maternal morbidity, hospital readmission, triage visits for hypertension, postpartum and primary care visit attendance, and multiple patient-reported outcome measures. All outcomes will be stratified by race (Black and non-Black) to evaluate disparities and by tight versus usual blood pressure control to evaluate the impact of strict postpartum blood pressure control on outcomes. Investigators hypothesize that a comprehensive postpartum HDP management program will improve hypertension control for all patients and reduce disparities that affect Black patients, and that stricter blood pressure control will be associated with fewer adverse outcomes.

NCT ID: NCT05775744 Completed - Clinical trials for Postpartum Preeclampsia

Management of Postpartum Preeclampsia

MOPP
Start date: March 28, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to assess the effect of a lower treatment threshold for antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease.

NCT ID: NCT05309460 Recruiting - Clinical trials for Hypertension in Pregnancy

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Start date: June 20, 2022
Phase: Phase 4
Study type: Interventional

Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.

NCT ID: NCT05159726 Completed - Clinical trials for Postpartum Depression

Postpartum Video Education

Start date: July 5, 2022
Phase: N/A
Study type: Interventional

This is a prospective, single-center, randomized control study to determine if video education at the time of postpartum discharge improves patient knowledge on the warning signs for the top three causes of severe maternal morbidity (infection, hemorrhage, and blood pressure disorders) in the first seven days following delivery. Participants will be randomized to written discharge education + video education (intervention) vs standard discharge education (control). They will complete a baseline questionnaire and a post-discharge education questionnaire during their postpartum stay to assess for knowledge improvement. The investigators hypothesize that video education will improve patient's knowledge of severe maternal morbidity warning signs.

NCT ID: NCT05139238 Not yet recruiting - Clinical trials for Postpartum Preeclampsia

Postpartum Hypertension Study

Start date: August 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess which blood pressure medication (intravenous labetalol or oral nifedipine) works better in treating severely elevated blood pressure in women who have just delivered a baby.

NCT ID: NCT05049616 Active, not recruiting - Clinical trials for Hypertension in Pregnancy

Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension

ACE
Start date: October 18, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to see if a combined pill of Angiotensin-converting enzyme (ACE) inhibitors (a medication that helps relax your veins and arteries to lower your blood pressure) with diuretics (sometimes called water pills, help rid your body of salt and water) will control blood pressure better than a different blood pressure medication of calcium channel blocker (lower your blood pressure by preventing calcium from entering the cells of your heart and arteries). Both medications are part of our usual care for high blood pressure after delivery.

NCT ID: NCT04752475 Completed - Hypertension Clinical Trials

Lasix for the Prevention of De Novo Postpartum Hypertension

LAPP
Start date: October 20, 2021
Phase: Phase 3
Study type: Interventional

Primary objective: To evaluate whether oral furosemide can help prevent de novo postpartum hypertension (new-onset high blood pressure after delivery) by reducing blood pressure after delivery in high-risk women. Secondary objectives: To evaluate whether oral furosemide administered to high-risk women after delivery can reduce the frequency of postpartum hypertensive episodes, the need for antihypertensive therapy, the risk of postpartum preeclampsia, and the incidence of severe maternal morbidity.

NCT ID: NCT04486170 Completed - Clinical trials for Hypertension in Pregnancy

Assessment of Postpartum Education to Improve Compliance

Start date: September 14, 2020
Phase: N/A
Study type: Interventional

This is a prospective single centered randomized control study for postpartum patients diagnosed with hypertension. Participants that meet inclusion criteria will be approached while they are inpatient. After enrollment, all study subjects will receive an automated blood pressure cuff and instructions on how to use it. Study participants in the intervention group will be provided with educational material. The investigators hypothesize education in postpartum women with hypertension can improve patient compliance with attendance at postpartum care appointments.

NCT ID: NCT04236258 Completed - Clinical trials for Hypertension in Pregnancy

Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period

Start date: January 24, 2020
Phase: Phase 4
Study type: Interventional

This study evaluates whether nifedipine or enalapril is better at decreasing the amount of medical resources used in the postpartum period by women who have high blood pressure in pregnancy and the postpartum period. Half of participants will receive enalapril while the other half will receive enalapril. We will compare the two groups in the amount of medical resources used which we are defining as prolonged hospitalizations, unscheduled medical visits and/or hospital readmissions in the postpartum period.